Reversal of end stage renal disease in patient with transcatheter aortic valve replacement

Abdulla Damluji; Martin S Bilsker; Mauricio G Cohen

doi:10.1002/ccd.25127

Reversal of end stage renal disease in patient with transcatheter aortic valve replacement

Catheter Cardiovasc Interv. 2014 Feb 15;83(3):482-4. doi: 10.1002/ccd.25127. Epub 2013 Aug 8.

Authors

Abdulla Damluji¹, Martin S Bilsker, Mauricio G Cohen

Affiliation

¹ Division of Cardiology and Elaine and Sydney Sussman Cardiac Catheterization Laboratory, Miller School of Medicine, University of Miami Hospital, Miami, Florida.

PMID: 23857778
DOI: 10.1002/ccd.25127

Abstract

Transcatheter aortic valve replacement (TAVR) has become an alternative intervention in high-risk and inoperable patients with symptomatic aortic valve stenosis. The procedure has been associated with favorable clinical outcomes and safety profile in patients with end stage renal disease (ESRD). We describe a case of improved kidney function in a patient with ESRD without further need for dialysis after TAVR.

Keywords: chronic renal insufficiency; paravalvular leaks; valvular heart disease.

Publication types

Case Reports

MeSH terms

Aged, 80 and over
Aortic Valve Stenosis / complications
Aortic Valve Stenosis / diagnosis
Aortic Valve Stenosis / therapy*
Cardiac Catheterization* / instrumentation
Echocardiography, Doppler
Heart Valve Prosthesis
Heart Valve Prosthesis Implantation / instrumentation
Heart Valve Prosthesis Implantation / methods*
Humans
Kidney / physiopathology*
Kidney Failure, Chronic / complications*
Kidney Failure, Chronic / diagnosis
Kidney Failure, Chronic / physiopathology
Kidney Failure, Chronic / therapy
Male
Prosthesis Design
Recovery of Function
Renal Dialysis
Severity of Illness Index
Treatment Outcome